EE176 A Cost Analysis on Complications of Fabry Disease Patients Treated with Agalsidase Alfa and Agalsidase Beta in Colombia
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.477
https://www.valueinhealthjournal.com/article/S1098-3015(23)00577-6/fulltext
Title :
EE176 A Cost Analysis on Complications of Fabry Disease Patients Treated with Agalsidase Alfa and Agalsidase Beta in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00577-6&doi=10.1016/j.jval.2023.03.477
First page :
Section Title :
Open access? :
No
Section Order :
11863